PT Diagnos Laboratorium Utama Tbk
IDX:DGNS.JK
246 (IDR) • At close October 30, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) IDR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 145,696.016 | 192,886.351 | 302,181.509 | 183,170.68 | 51,337.677 | 38,552.837 | 14,014.01 |
| Cost of Revenue
| 86,384.322 | 104,488.067 | 154,538.056 | 97,268.782 | 31,852.519 | 22,018.25 | 9,310.881 |
| Gross Profit
| 59,311.694 | 88,398.284 | 147,643.453 | 85,901.899 | 19,485.157 | 16,534.587 | 4,703.129 |
| Gross Profit Ratio
| 0.407 | 0.458 | 0.489 | 0.469 | 0.38 | 0.429 | 0.336 |
| Reseach & Development Expenses
| 249.045 | 586.171 | 273.575 | 593.36 | 425.891 | 0 | 0 |
| General & Administrative Expenses
| 63,675.07 | 65,326.889 | 52,146.855 | 16,257.225 | 5,156.147 | 3,294.211 | 2,023.321 |
| Selling & Marketing Expenses
| 9,744.663 | 12,993.539 | 13,078.021 | 1,974.073 | 1,085.191 | 465.128 | 386.56 |
| SG&A
| 73,419.733 | 70,009.501 | 66,093.485 | 18,281.005 | 5,856.5 | 4,096.488 | 2,763.209 |
| Other Expenses
| -154.591 | -143.984 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 72,801.503 | 70,739.655 | 66,367.06 | 18,874.365 | 6,282.392 | 4,096.488 | 2,763.209 |
| Operating Income
| -15,151.21 | 17,658.628 | 81,276.394 | 67,027.534 | 13,202.766 | 12,438.1 | 1,939.92 |
| Operating Income Ratio
| -0.104 | 0.092 | 0.269 | 0.366 | 0.257 | 0.323 | 0.138 |
| Total Other Income Expenses Net
| 1,578.408 | -325.158 | 2,002.478 | -52.456 | -559.337 | -210.132 | -139.769 |
| Income Before Tax
| -13,572.802 | 17,333.47 | 83,278.872 | 66,975.078 | 12,643.429 | 12,227.968 | 1,800.151 |
| Income Before Tax Ratio
| -0.093 | 0.09 | 0.276 | 0.366 | 0.246 | 0.317 | 0.128 |
| Income Tax Expense
| 83.004 | 4,668.58 | 18,975.366 | 14,288.539 | 3,368.838 | 2,963.215 | 418.24 |
| Net Income
| -13,655.806 | 12,664.89 | 64,303.506 | 52,686.538 | 9,274.591 | 9,264.753 | 1,381.911 |
| Net Income Ratio
| -0.094 | 0.066 | 0.213 | 0.288 | 0.181 | 0.24 | 0.099 |
| EPS
| -10.92 | 10.13 | 51.84 | 42.15 | 7.42 | 7.41 | 1.11 |
| EPS Diluted
| -10.92 | 10.13 | 51.84 | 42.15 | 7.42 | 7.41 | 1.11 |
| EBITDA
| -3,604.18 | 30,893.16 | 88,838.17 | 70,869.477 | 15,458.379 | 12,847.471 | 1,989.534 |
| EBITDA Ratio
| -0.025 | 0.16 | 0.294 | 0.387 | 0.301 | 0.333 | 0.142 |